Medications for Opioidinduced Constipation

8 results
Asclemed USA, Inc.
Usage: Lubiprostone is indicated for the treatment of chronic idiopathic constipation (CIC) in adults, opioid-induced constipation (OIC) in adults with chronic non-cancer pain, and irritable bowel syndrome with constipation (IBS-C) in women aged 18 and older. Its effectiveness for certain opioid types remains unestablished.
Asclemed USA, Inc.
Usage: Lubiprostone capsules are indicated for treating chronic idiopathic constipation in adults, opioid-induced constipation in adults with chronic non-cancer pain, and irritable bowel syndrome with constipation in women aged 18 and older. Its effectiveness for opioid-induced constipation with certain opioids has not been established.
Advanced Rx Pharmacy of Tennessee, LLC
Usage: Lubiprostone is indicated for treating chronic idiopathic constipation (CIC) in adults, opioid-induced constipation (OIC) in adults with chronic non-cancer pain, and irritable bowel syndrome with constipation (IBS-C) in women aged 18 and older. Effectiveness in patients taking methadone for OIC is not established.
Advanced Rx Pharmacy of Tennessee, LLC
Usage: Lubiprostone is indicated for treating chronic idiopathic constipation (CIC) in adults, opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, and irritable bowel syndrome with constipation (IBS-C) in women over 18 years old. Effectiveness for OIC with certain opioids has not been established.

Movantik (naloxegol oxalate)

(naloxegol oxalate)
RedHill Biopharma Ltd
Usage: MOVANTIK® is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including those with pain related to prior cancer or its treatment, who do not require frequent opioid dosage escalation.

Movantik (naloxegol oxalate)

(naloxegol oxalate)
Valinor Pharma, LLC
Usage: MOVANTIK® is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with chronic pain from prior cancer or its treatment, provided they do not require frequent opioid dosage escalation.

Relistor (methylnaltrexone bromide)

(Methylnaltrexone bromide)
Salix Pharmaceuticals Inc
Usage: RELISTOR is indicated for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain and those with advanced illness requiring opioid dosage escalation for palliative care. It is available in both tablet and injection forms.
BioDelivery Sciences International Inc
Usage: SYMPROIC is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with pain related to prior cancer or treatment, who do not need frequent opioid dosage increases.